Trials / Completed
CompletedNCT03404570
Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis
A Double-Blind, Randomized, Placebo-Controlled Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Moderate to Severe Palmar Hyperhidrosis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Atacama Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot exploratory study to evaluate the safety and efficacy of TC-5214 in subjects with palmar hyperhidrosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmecamylamine HCl | Investigational drug |
| OTHER | Placebo | Oral tablet containing no active drug. |
Timeline
- Start date
- 2017-12-21
- Primary completion
- 2019-01-18
- Completion
- 2019-01-18
- First posted
- 2018-01-19
- Last updated
- 2019-11-21
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03404570. Inclusion in this directory is not an endorsement.